EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 15 June 2023

Pharma reform: Patients can’t afford to wait. Act now.

Waiting five years to try and fix patient access while we watch EU competitiveness decline is not the solution.

In POLITICO, Nathalie Moll, EFPIA Director General outlines how, together, we can evolve the new EU pharmaceutical legislation to make a difference, to back innovation and boost access in Europe.

IHI Calls 4 and 5: Publication of draft topics and opening of registration to call days
12 June 2023

IHI Call Days: Calls 4 & 5 Read more

Blog

Industry disclosure of payments to health professionals and patients: Improving access to data...
15 June 2023 - Darren Knott

EFPIA launches a new European gateway, an easy-to-navigate platform which connects all information disclosed by EFPIA... Read more

Shared decision making in kidney cancer: combining clinical evidence and patient preference...
15 June 2023 - Bryan Qvick

This year, we will continue to not only raise awareness of the importance of shared decision making in kidney cancer,... Read more

The patient expert who lived with an antimicrobial resistant infection for 15 years before...
14 June 2023 - Thomas Smith

Experience of living with Cystic Fibrosis (CF) and the impact AMR on one's health journey and the wider CF patient community... Read more

How is your country treating your heart?
12 June 2023 - Christian Thonke - Victoria Tzouma

A set of CVD data across 22 European countries to see how CVD trends have developed over time, the existing disparities... Read more

Events

How the pharmaceutical industry is working to avoid and replace the use of animals for scientific...
22 June 2023 (Zoom)

An online event co-organised by EFPIA and the RSPCA Read more

IHI Call Days: Calls 4 & 5
19 June 2023 (Online)

The aim of the IHI Call Days is to provide potential applicants with the information they need to put together a strong... Read more

European Disclosure Gateway

As part of its support for greater transparency, the pharmaceutical industry has voluntarily created a single point of access to help any interested stakeholder navigate the publicly available data on details of payments and other benefits in kind made by the industry to HCPs and HCOs across all EFPIA Members countries. Navigate the European Gateway map here!

What we are reading

Rare Diseases Moonshot partners welcome the pre-publication of the draft future Innovative...
On 14 June 2023 (Rare Disease Moonshot)

The Rare Disease (RD) Moonshot partners welcome the inclusion of the rare and ultra-rare diseases in a recent IHI... Read more

Innovative Health Initiative launches first five projects
On 14 June 2023 (IHI)

Addressing cancer and neurodegenerative diseases, and bringing on board sectors as diverse as pharmaceuticals, medical... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu